Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I TrialVincent Chung, John S. Kovach, Henry J. Durivage et al.|Clinical Cancer Research|2016Cited by 126
Metastatic breast cancer: preliminary results with oral hormonal therapy.Joseph C. Allegra, Lawrence Einhorn, Joseph Bertino et al.|PubMed|1985Cited by 17